| Julie O'leary, RN | |
|
24 Beauty Hill Rd, Center Barnstead, NH 03225-3705 | |
| (866) 488-0445 | |
| Not Available |
| Full Name | Julie O'leary |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 24 Beauty Hill Rd, Center Barnstead, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194308767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 071962-21 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie O'leary, RN 24 Beauty Hill Rd, Center Barnstead, NH 03225-3705 Ph: (603) 856-6941 | Julie O'leary, RN 24 Beauty Hill Rd, Center Barnstead, NH 03225-3705 Ph: (866) 488-0445 |
News Archive
In perfecting the science of medicine, advancements always face exhaustive scrutiny and opposition. Typically, these rigors focus on confirming the efficacy of a procedure or treatment to ensure it remains in the patient's best interest for healing or wellness. More recently, with heightened emphasis on government-funded healthcare, medical procedures such as robotic prostatectomy surgery for prostate cancer treatment are under fire for cost.
In the first trial of its kind in the world, 60 patients who have recently suffered a major heart attack will be injected with selected stem cells from their own bone marrow during routine coronary bypass surgery.
From the moment people learn to walk, many are taught that exercise is the key to living a healthy life. Indeed, the long-term benefits of exercise are indisputable.
Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.
› Verified 6 days ago